RxDoctor Payments Data

Joshua Frank, MD

Sports Medicine · Norwalk, CTNPI 1598898843

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $72,199 of the $77,970 with a category attached, or 92.6%. Depuy Synthes Products, Inc. accounts for 92.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $28,082 and has fallen 98.2% since, to $497 in 2025. Among sports medicine clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$77,970in general payments, 2019–2025

Across 94 payments — averaging $829.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$72K
  • Gotham Surgical Solutions & Devices, Inc.$1K
  • Arthrex$1K
  • Johnson & Johnson$916
  • Vericel Corporation$711
  • Stryker$463
  • plus $1K from 9 others

What the payments were for

  • Royalty or licence$72,19993%
  • Speaking & faculty fees$5501%
  • Travel & lodging$8361%
  • Food & beverage$3,1854%
  • Education$1,2002%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$77,970 in reported general payments places this provider in the 90th percentile of 65 sports medicine providers in Connecticut.

See all sports medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$278,167
Medicare patients
468
Services billed
12,069

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam226$668
Methylprednisolone91$655
Celecoxib16$224
Prednisone49$185
Cyclobenzaprine Hcl17$104
Ondansetron Hcl27$93

Paid to pharmacies, not to this prescriber.

Other sports medicine in Norwalk

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →